Impact of an Antioxidant Alimentary Complement on Sperm Data
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01841034|
Recruitment Status : Unknown
Verified February 2013 by Centre Hospitalier Universitaire de Nice.
Recruitment status was: Recruiting
First Posted : April 26, 2013
Last Update Posted : April 26, 2013
|Condition or disease||Intervention/treatment|
|Infertility||Drug: Conceptio EA|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Evaluation of a 6 Months Treatment of Conceptio (EA) on Sperm Data in Infertile Men With Oligoasthenozoospermia|
|Study Start Date :||September 2011|
|Estimated Primary Completion Date :||June 2013|
|Estimated Study Completion Date :||December 2013|
Any patient receipt within the framework of the coverage(care) of an infertility in the pole ORG, whatever is the étiologie and the type of treatment proposing and presenting during at least two spermogrammes an oligospermie and\or an asthénospermie. The necessity of realizing 2 spermogrammes different to determine the pathological character of the values of a spermogramme takes into account the personal variability of the results.
Drug: Conceptio EA
The patients are included during a consultation whether it is with a clinician or a biologist of the Center. It is suggested in routine in the service, to all the patients consulting for a problem of infertility and presenting pathological spermatic data, taking the food complement Conceptio. At the patients wishing to take this complement it will be suggested participating in this study. This complement is usually bought by the patient, within the framework of this study this one will be gracefully supplied. The follow-up of the patient will contain no examination and no anybody visit besides the usually realized follow-up.
- Spermatic parameters (numeration and mobility spermatic) [ Time Frame: At the inclusion and 6 months after the inclusion ]The spermatic parameters used within the framework of the spermogramme made in routine in the Laboratory of Biology of the Reproduction will be the numeration and the spermatic mobility from the very beginning.
- Rate of fragmentation of the DNA [ Time Frame: At the inclusion and 6 months after the inclusion ]We shall consider the rate of fragmentation of the DNA determined according to the method of the TUNEL. This technique allows to estimate the rate of spermatozoides apoptose. It brings to light the fragmentation of the spermatic DNA in the course of process of cellular death.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01841034
|Contact: ISNARD Véronique, PH||+3349206403 ext +email@example.com|
|Contact: BENHAMED Mohamed, MDfirstname.lastname@example.org|
|CHU de Nice - Hôpital de l'Archet||Recruiting|
|Nice, Alpes-Maritimes, France, 06001|
|Contact: ISNARD Véronique, PH +3349206403 email@example.com|
|Contact: BENHAMED Mohamed, MD +3349206403 firstname.lastname@example.org|
|Principal Investigator: ISNARD Véronique, PH|
|Principal Investigator:||ISNARD Véronique, PH||CHU de Nice - CECOS- Hôpital de l'Archet - 151 Route de saint-antoine de ginestière 06200 Nice|